chlorpromazine has been researched along with chitosan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, K; Bjørkøy, A; Davies, Cde L; Folasire, O; Garaiova, Z; Lélu, S; Malmo, J; Reitan, NK; Strand, SP; Størset, SØ | 1 |
| Chen, Y; Dong, Q; Feng, J; Gu, T; Kong, W; Sun, Y; Wang, M; Wu, Y; Yang, X; Zhang, Y | 1 |
| Hergert, P; Im, J; Jeon, S; Kim, H; Kim, K; Nho, RS; Panyam, J; Yhee, JY; Yoon, HY | 1 |
| Rukmangathen, R; Yalavarthi, PR; Yallamalli, IM | 1 |
4 other study(ies) available for chlorpromazine and chitosan
| Article | Year |
|---|---|
Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways.
Topics: Caveolae; Chitosan; Chlorpromazine; Clathrin; DNA; Drug Carriers; Endocytosis; Genistein; HeLa Cells; Humans; Hydrazones; Nanoparticles; Surface Properties; Temperature; Transfection | 2012 |
Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Topics: Amiloride; Animals; Cell Survival; Chitosan; Chlorpromazine; Dogs; Drug Carriers; Exenatide; Intestinal Absorption; Lactic Acid; Madin Darby Canine Kidney Cells; Male; Models, Biological; Nanoparticles; Particle Size; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Spectrometry, Fluorescence; Venoms | 2013 |
The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts.
Topics: Amiloride; Cells, Cultured; Chitosan; Chlorpromazine; Collagen Type I; Drug Carriers; Drug Delivery Systems; Endocytosis; Extracellular Matrix; Fibroblasts; Genistein; Humans; Idiopathic Pulmonary Fibrosis; Lung; Nanoparticles; Phosphatidylinositol 3-Kinases | 2017 |
Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Brain; Catalase; Catalepsy; Chitosan; Chlorpromazine; Female; Glutathione; Male; Nanoparticles; Nitrites; Parkinson Disease; Rats, Wistar; Selegiline; Thiobarbituric Acid Reactive Substances | 2019 |